| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |